| Expression pattern: |
UP |
| Associated gene: |
IGF2 |
| Associated microRNA: |
miR-615-3p |
| Biological function: |
promotes ovarian cancer cell proliferation, migration, invasion, tumor growth and lung metastasis |
| Molecular mechanism: |
circ-TFRC acts as a miR-615-3p sponge to promote IGF2 expression |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
H
|
| Validation methods: |
RT-qPCR; FISH / smFISH; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Transwell Assay; In Vivo Animal Model; IHC (Immunohistochemistry); H&E Staining |
| Clinical significance: |
high circ-TFRC expression indicated a poor prognosis of OC |
| Description: |
circ-TFRC (hsa_circ_0068631) is up-regulated in ovarian cancer tissues/cells and mainly localized in the cytoplasm. Silencing circ-TFRC suppresses OC proliferation, migration/invasion, tumor growth and lung metastasis by acting as a ceRNA to sponge miR-615-3p and thereby increase IGF2 expression. |
| Confidence score: |
0.7369 |